Related Experiment Video
Updated: Jun 5, 2026

Comprehensive Echocardiographic Assessment of Right Ventricle Function in a Rat Model of Pulmonary Arterial Hypertension
Published on: January 20, 2023
Increased left ventricular torsion in hypertrophic cardiomyopathy mutation carriers with normal wall thickness
Iris K Rüssel1, Wessel P Brouwer, Tjeerd Germans
1Department of Clinical Physics, Hagaziekenhuis, The Hague, The Netherlands. i.russel@hagaziekenhuis.nl
Insights
Healthy carriers of hypertrophic cardiomyopathy (HCM) gene mutations show increased left ventricular (LV) torsion and torsion-to-endocardial-circumferential-shortening (TECS) ratio, suggesting early subendocardial dysfunction. These findings may guide interventions to prevent HCM onset.
Area of Science:
- Cardiology
- Genetics
- Biomedical Imaging
Background:
- Increased left ventricular (LV) torsion is a known characteristic of manifest familial hypertrophic cardiomyopathy (HCM).
- This torsion is hypothesized to stem from underlying subendocardial dysfunction.
- Early detection of cardiac changes in mutation carriers is crucial for understanding disease progression.
Purpose of the Study:
- To investigate whether increased LV torsion is present in healthy mutation carriers before the development of significant wall thickening.
- To identify potential early markers of myocardial dysfunction in individuals at risk for HCM.
Main Methods:
- Cardiovascular magnetic resonance (CMR) with tissue tagging was used in 17 healthy HCM gene carriers (LV wall thickness <10 mm) and 17 controls.
- LV volumes, mass, torsion, torsion rate, endocardial circumferential strain, and the torsion-to-endocardial-circumferential-shortening (TECS) ratio were quantified.
- The TECS ratio was used to assess transmural distribution of contractile function.
Main Results:
- LV volumes, mass, and endocardial circumferential strain were similar between carriers and controls.
- Carriers exhibited significantly increased LV ejection fraction, torsion, and TECS ratio compared to controls.
- These findings indicate altered LV mechanics in asymptomatic carriers.
Conclusions:
- Healthy HCM gene carriers with normal wall thickness demonstrate elevated LV torsion and TECS ratio.
- These abnormalities suggest subendocardial myocardial dysfunction, mirroring findings in manifest HCM.
- These early changes represent potential targets for therapeutic interventions to delay or prevent HCM development.
Background:
Increased left ventricular (LV) torsion has been observed in patients with manifest familial hypertrophic cardiomyopathy (HCM), and is thought to be caused by subendocardial dysfunction. We hypothesize that increased LV torsion is already present in healthy mutation carriers with normal wall thickness.
Methods:
Seventeen carriers with an LV wall thickness <10 mm, and seventeen age and gender matched controls had cardiovascular magnetic resonance (CMR) cine imaging and tissue tagging. LV volumes and mass were calculated from the cine images. LV torsion, torsion rate, endocardial circumferential strain and torsion-to-endocardial-circumferential-shortening (TECS) ratio, which reflects the transmural distribution in contractile function, were determined using tissue tagging.
Results:
LV volumes, mass and circumferential strain were comparable between groups, whereas LV ejection fraction, torsion and TECS-ratio were increased in carriers compared to controls (63 ± 3% vs. 60 ± 3%, p = 0.04, 10.1 ± 2.5° vs. 7.7 ± 1.2°, p = 0.001, and 0.52 ± 0.14°/% vs. 0.42 ± 0.10°/%, p = 0.02, respectively).
Conclusions:
Carriers with normal wall thickness display increased LV torsion and TECS-ratio with respect to controls, which might be due to subendocardial myocardial dysfunction. As similar abnormalities are observed in patients with manifest HCM, the changes in healthy carriers may be target for clinical intervention to delay or prevent the onset of hypertrophy.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Heart Failure II: Pathophysiology
Cardiomyopathy II: Dilated Cardiomyopathy
Mitral Valve Prolapse I: Introduction
Mitral Regurgitation I: Introduction
Aortic Regurgitation II: Clinical Features and Diagnostic Tests

